Beam Therapeutics

Beam Therapeutics is developing precision genetic medicines for serious diseases. Co-founded by scientific pioneers known for advancing CRISPR gene editing, Beam is the first company to pursue development of new therapies using CRISPR base editing technology. Beam aims to use these technologies to generate a broad pipeline of precision genetic medicines that repair disease-causing point…

Cell Design Labs

Cell Design Labs is a biotherapeutics company pioneering breakthrough science to develop disruptive cell-based therapies for cancer and other devastating diseases. Their proprietary ON-OFF switches and synthetic Notch receptors provide T-cells with a far greater capability to recognize cancer and other disease tissues in a precise and controlled manner. This new toolkit for cellular engineering…

DICE Therapeutics

DiCE Molecules is a biotechnology company utilizing its proprietary DNA-encoded library (DEL) technology, combined with unique structural insights, to generate small molecule antagonists against a range of protein-protein-interface (PPI) targets. The DiCE DEL strategy relies on well-curated libraries of compounds that are customized on a target-by-target basis, allowing the Company to carry out medicinal chemistry…

Prime Medicine

Prime Medicine is a biotechnology company founded to deliver on the promise of Prime Editing, a versatile gene editing technology that can truly “search and replace” to restore normal genetic function and address the fundamental causes of disease. Prime Medicine envisions a world where Prime Editing can cure, halt, and ultimately prevent genetic diseases, providing…

ReCode Therapeutics

ReCode Therapeutics is a startup developing novel treatments for genetic lung diseases like cystic fibrosis and primary ciliary dyskinesia. ReCode Therapeutics was formed by combining two companies, Transcriptx and ReCode Therapeutics, that were developing the mRNA and lipid nanoparticle technology respectively. The combined entity, ReCode Therapeutics, has a more expanded focus on genetic diseases with…

Sana Biotechnology

Sana Biotechnology is creating and delivering engineered cells as medicine for patients. The company was founded in 2016 by world-renowned scientific founders including Chad Cowan of Harvard, Sonja Schrepfer of UC San Francisco, Chuck Murry of UW, Richard Mulligan of Harvard, David Baker of UW and HHMI, and the scientific team at Flagship Labs led…